Mirova Has $11.37 Million Stock Position in Colgate-Palmolive Company $CL

Mirova increased its position in shares of Colgate-Palmolive Company (NYSE:CL) by 8.5% during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 142,187 shares of the company’s stock after buying an additional 11,168 shares during the period. Colgate-Palmolive accounts for approximately 1.6% of Mirova’s investment portfolio, making the stock its 16th biggest position. Mirova’s holdings in Colgate-Palmolive were worth $11,366,000 at the end of the most recent reporting period.

A number of other large investors have also recently added to or reduced their stakes in CL. S.A. Mason LLC raised its holdings in shares of Colgate-Palmolive by 3.9% in the 3rd quarter. S.A. Mason LLC now owns 3,499 shares of the company’s stock valued at $280,000 after purchasing an additional 130 shares during the period. Security National Bank of Sioux City Iowa IA raised its stake in Colgate-Palmolive by 0.8% in the 3rd quarter. Security National Bank of Sioux City Iowa IA now owns 16,241 shares of the company’s stock valued at $1,298,000 after acquiring an additional 130 shares during the period. Stratos Wealth Advisors LLC lifted its stake in shares of Colgate-Palmolive by 4.5% during the 3rd quarter. Stratos Wealth Advisors LLC now owns 3,015 shares of the company’s stock worth $241,000 after buying an additional 130 shares during the last quarter. Chicago Partners Investment Group LLC lifted its position in Colgate-Palmolive by 1.5% during the third quarter. Chicago Partners Investment Group LLC now owns 9,387 shares of the company’s stock worth $724,000 after acquiring an additional 136 shares during the last quarter. Finally, Cary Street Partners Investment Advisory LLC boosted its stake in Colgate-Palmolive by 17.7% in the 2nd quarter. Cary Street Partners Investment Advisory LLC now owns 911 shares of the company’s stock valued at $83,000 after purchasing an additional 137 shares during the period. Institutional investors and hedge funds own 80.41% of the company’s stock.

Insider Activity at Colgate-Palmolive

In other Colgate-Palmolive news, insider John Hazlin sold 20,989 shares of the company’s stock in a transaction dated Tuesday, February 10th. The stock was sold at an average price of $94.25, for a total value of $1,978,213.25. Following the completion of the transaction, the insider owned 17,645 shares of the company’s stock, valued at $1,663,041.25. This represents a 54.33% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, COO Panagiotis Tsourapas sold 15,000 shares of Colgate-Palmolive stock in a transaction dated Thursday, February 12th. The shares were sold at an average price of $97.81, for a total value of $1,467,150.00. Following the sale, the chief operating officer directly owned 10,415 shares in the company, valued at $1,018,691.15. The trade was a 59.02% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Over the last three months, insiders have sold 184,683 shares of company stock worth $17,486,693. Corporate insiders own 0.34% of the company’s stock.

Colgate-Palmolive Price Performance

Colgate-Palmolive stock opened at $87.56 on Thursday. The company has a debt-to-equity ratio of 18.82, a quick ratio of 0.54 and a current ratio of 0.83. Colgate-Palmolive Company has a 52 week low of $74.54 and a 52 week high of $99.33. The stock has a market capitalization of $70.58 billion, a P/E ratio of 33.42, a price-to-earnings-growth ratio of 4.03 and a beta of 0.28. The stock has a fifty day moving average of $90.85 and a 200-day moving average of $83.34.

Colgate-Palmolive (NYSE:CL) last released its earnings results on Friday, January 30th. The company reported $0.95 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.91 by $0.04. The firm had revenue of $5.23 billion for the quarter, compared to analysts’ expectations of $5.13 billion. Colgate-Palmolive had a return on equity of 353.72% and a net margin of 10.45%.The business’s revenue for the quarter was up 5.8% on a year-over-year basis. During the same quarter in the previous year, the business posted $0.91 earnings per share. On average, sell-side analysts expect that Colgate-Palmolive Company will post 3.75 earnings per share for the current fiscal year.

Colgate-Palmolive Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, May 15th. Investors of record on Monday, April 20th will be paid a $0.53 dividend. This represents a $2.12 annualized dividend and a yield of 2.4%. The ex-dividend date of this dividend is Monday, April 20th. This is a positive change from Colgate-Palmolive’s previous quarterly dividend of $0.52. Colgate-Palmolive’s payout ratio is currently 79.39%.

Wall Street Analyst Weigh In

Several analysts have weighed in on CL shares. Piper Sandler lifted their price objective on shares of Colgate-Palmolive from $88.00 to $96.00 and gave the stock an “overweight” rating in a research note on Friday, January 30th. Wells Fargo & Company raised their price objective on Colgate-Palmolive from $86.00 to $94.00 and gave the stock an “equal weight” rating in a research note on Sunday, February 1st. Weiss Ratings reissued a “hold (c)” rating on shares of Colgate-Palmolive in a report on Wednesday, January 21st. Rothschild & Co Redburn set a $93.00 price target on Colgate-Palmolive in a research note on Friday, February 13th. Finally, UBS Group increased their price objective on shares of Colgate-Palmolive from $90.00 to $93.00 and gave the stock a “buy” rating in a research note on Wednesday, January 14th. Eleven research analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the company. According to data from MarketBeat, the stock has an average rating of “Moderate Buy” and an average target price of $94.75.

Colgate-Palmolive Profile

Colgate-Palmolive Company is a global consumer products company with a long history in household and personal care categories. The business traces its roots to the early 19th century and has evolved into a multinational manufacturer and marketer of everyday consumer goods focused on health, hygiene and home care.

The company’s core activities center on oral care, personal care, home care and pet nutrition. Its product portfolio includes toothpaste, toothbrushes and mouthwash in oral care; soaps, body washes and deodorants in personal care; dishwashing liquids, surface cleaners and other household products in home care; and scientifically formulated pet foods under its pet nutrition business.